Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obesity; Type 2 Diabetes”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Not applicableStudy completedNCT06912555
What this trial is testing

Effect of Low-calorie Diets With Different Macronutrient Composition and Macronutrient Distribution in Shift Workers With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

Who this might be right for
Type 2 DiabetesOverweight or ObesityPreDiabetes
Universidad de Zaragoza 120
Early research (Phase 1)Study completedNCT06567041
What this trial is testing

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Novo Nordisk A/S 82
Not applicableActive Not RecruitingNCT06473831
What this trial is testing

MagDI Australia Study

Who this might be right for
ObesityType 2 Diabetes
GT Metabolic Solutions, Inc. 25
Not applicableLooking for participantsNCT03875625
What this trial is testing

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity, MorbidBrown Fat+4 more
Chinese University of Hong Kong 80
Large-scale testing (Phase 3)Active Not RecruitingNCT06858839
What this trial is testing

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Who this might be right for
Obesity
Amgen 3,853
Not applicableLooking for participantsNCT06694012
What this trial is testing

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Type 2 DiabetesDiabetes Mellitus+16 more
Osaka Metropolitan University 2,000
Post-approval studies (Phase 4)Study completedNCT01051674
What this trial is testing

A Very High Fiber Diet Versus a Low-carbohydrate Diet for Weight Loss

Who this might be right for
ObesityType 2 Diabetes
Loma Linda University 173
Testing effectiveness (Phase 2)Study completedNCT02871882
What this trial is testing

Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusObeseOverweight
Mayo Clinic 24
Large-scale testing (Phase 3)Study completedNCT01306214
What this trial is testing

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Boehringer Ingelheim 566
Early research (Phase 1)Study completedNCT00806338
What this trial is testing

An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Who this might be right for
Diabetes MellitusObesity
Genaera Corporation 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06737042
What this trial is testing

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Who this might be right for
Obesity and Overweight
Gan and Lee Pharmaceuticals, USA 285
Large-scale testing (Phase 3)Not Yet RecruitingNCT07400107
What this trial is testing

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Who this might be right for
ObesityOverweightDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,000
Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Large-scale testing (Phase 3)Study completedNCT01272232
What this trial is testing

Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 846
Post-approval studies (Phase 4)Not Yet RecruitingNCT07555730
What this trial is testing

AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

Who this might be right for
Overweight or Obesity; Type 2 DiabetesWeight Loss Maintenance
Huazhong University of Science and Technology 400
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Testing effectiveness (Phase 2)Looking for participantsNCT06897475
What this trial is testing

LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 240
Not applicableStudy completedNCT00922194
What this trial is testing

Metformin in Overweight Type 2 Diabetes Mellitus

Who this might be right for
ObesityType 2 Diabetes Mellitus
Era's Lucknow Medical College 102
Large-scale testing (Phase 3)UnknownNCT02235519
What this trial is testing

Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients

Who this might be right for
HypertensionObesityType 2 Diabetes Mellitus
Hospital General de México Dr. Eduardo Liceaga 300
Load More Results